New treatment plan may extend survival for cervical cancer patients

In some good news for women battling locally advanced cervical cancer, new research shows that adding six weeks of chemotherapy to standard treatment cuts the risk of death by 40%.

"This is the biggest improvement in outcome in this disease in over 20 years," lead investigator Dr. Mary McCormack, from University College London's Cancer Institute, said in a news release from Cancer Research UK, which funded the trial. "I'm incredibly proud of all the patients who participated in the trial; their contribution has allowed us to gather the evidence needed to improve treatment of cervical cancer patients everywhere."

Advertisement